Navigation Links
Santaris in Medical News

Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines

COLLEGEVILLE, Pa., & HOERSHOLM, Denmark, Jan. 12 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), and Santaris Pharma today announced that the companies have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines bas...
Santaris in Medical Technology

Another LNA-based RNA Inhibitor Enters Clinical Trials

... COPENHAGEN, March 20 /PRNewswire/ -- santaris Pharma announced today that the fourth LNA-based d... Survivin inhibitor, which is jointly developed by santaris Pharma and Enzon Pharmaceuticals. The U.S. Food an...lls" http://www.santaris.com About santaris Pharma ...

Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research

...ymphocytic Leukaemia COPENHAGEN, 18 April 2007 - santaris Pharma, the Danish biopharmaceutical company devel...ts at the University of Duisberg-Essen in Germany, santaris researchers reported that white blood cells obtain...tact: Dr. Keith McCullagh President & CEO, santaris Pharma, Tel: +45 4517 9819, Cell:+44 7939 573548...

Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia

...y of Adult Leukaemia Copenhagen, 6th June 2007 - santaris Pharma, the Danish biopharmaceutical company, anno...nd more common tumour type. Dr Lene Worsaae Dalby, santaris Pharma's Vice-President of Clinical Development, s...ntrations. Following this second Phase I/II study, santaris expects to commence randomised Phase II studies in...
Santaris in Biological Technology

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... is scheduled to commence in Q3 2009. - santaris Pharma's new lead candidate SPC4955 targeting ...20/344344 ) During the first half of 2009 santaris Pharma continued to make satisfactory progress in ...tis virus replication in the liver. In April 2009, santaris Pharma completed a Phase I First-in-Man single dos...

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

... COPENHAGEN, June 4 /PRNewswire/ -- santaris Pharma today announced that the cancer drug EZN-29...ha, jointly developed by Enzon Pharmaceuticals and santaris Pharma A/S - was well tolerated and showed early s...edules. The HIF-1 alpha inhibitor is licensed from santaris Pharma A/S. The collaboration between...

Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark

... COPENHAGEN, June 3 /PRNewswire/ -- santaris Pharma and Copenhagen Institute of Technology, Aal...enmark, announced today that Director of microRNA, santaris Pharma, Sakari Kauppinen, has been appointed Adjun...Sakari Kauppinen, Director of MicroRNA Research at santaris Pharma said: "I feel very honored to be app...

Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule

...drugs within a short time span," said Henrik 0rum, santaris Pharma's Chief Scientific Officer. santaris Pharma and Enzon Pharmaceuticals signed their agreement in 2006. As part of the agreement santaris Pharma retains the lucrative commercial rights to ...

LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs

... COPENHAGEN, April 20 /PRNewswire/ -- santaris Pharma announced today promising findings on the i...ated RNAs, including microRNAs," said Henrik 0rum, santaris Pharma's Chief Scientific Officer. "These results ...rapeutics within a range of disease areas." santaris Pharma is a leader within microRNA research and is...

Affitech Appoints Dr. Keith McCullagh as Chairman

...preneurial track record in the biopharmaceutical industry, most recently at santaris Pharma in Denmark, where as CE0 he has played a major role in establishing ...ence industry. Most recently, from October 2003 to June 2008, he was CEO of santaris Pharma, a Danish biopharmaceutical company. From 2000 to 2003 he was execut...

IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference

...y Sector Shanghai, China GammaStar Medical Devices Group Ltd. Hoersholm, Denmark santaris BioPharmaceutical Pharmaceutical California, USA Napo Pharmaceutical BioPharmaceutical ...

Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008

... COPENHAGEN, Denmark, Feb. 11 /PRNewswire/ -- santaris Pharma, the Danish biopharmaceutical company devel... February 11th-13th, 2008. A live webcast of the santaris Pharma presentation may be accessed from the news ...ived and available after the presentation. About santaris Pharma ...

Danish Hotspot in Personalized Medicine

...ine in Denmark: Within diagnostics: Dako, Exiqon, FluimediX and Medical Prognostic Institute. Within drug discovery: Genmab, Novo Nordisk, Pharmexa, santaris Pharma and TopoTarget. For further information: Vibeke Dalhoff Tel.:+45-33-26-87-22 +45-61-26-464 email: vda@copcap.com Gitte Pedersen tel...
Other Tags
(Date:9/1/2015)... ... September 01, 2015 , ... Situations requiring fast, easy-to-understand business ... most convenient time for everyone involved. These occasions highlight the value of a ... Services has real people available to handle any translation assignment at any ...
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... announced today it has established the MAP Recovery Network, the Premier Outcomes-Driven ... treatment providers. This rapidly-growing alliance is dedicated to the provision of quality ...
(Date:9/1/2015)... ... September 01, 2015 , ... Elizabeth Callahan, MD, founder and medical director of ... area to offer RADIESSE® filler treatment for volume loss in the hands. RADIESSE provides ... veins in the hands, delivering smooth, natural-looking results that can last up to one ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... sponsored an educational workshop for physician assistants (PAs) practicing in orthopedics. The workshop, ... Zeel™” was held by Dr. Erick Salado, an orthopedic surgeon at South Florida ...
(Date:9/1/2015)... ... 01, 2015 , ... Curly Hair Solutions™ is thrilled to ... anticipated partnership between Curly Hair Solutions™ and Trade Secrets allows for nationwide distribution ... the Curly Hair Solutions™ team could not be more delighted to see their ...
Breaking Medicine News(10 mins):Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2
(Date:8/4/2015)... N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) today ... 30, 2015. Highlights: , Second quarter contract ... from 2014 , Adjusted contract margins of ... of $0.22, including a $0.05 decrease in EPS from royalties in ... $16 million "We are very pleased to present ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 ... sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 ... . La conferencia celebra su décimo ... se ha convertido en una de las reuniones anuales ... ,ómicas, y es una de las conferencias científicas más ...
(Date:7/31/2015)... julio de 2015 La 10 th International ... medio de BGI del 22 al 25 de octubre de 2015 ... Este año, la conferencia celebra su décimo aniversario. Desde su ... una de las reuniones anuales más influyentes del mundo en ... más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
Other Contents